Teva Pharma Industries  logo
TEVATeva Pharma Industries
Trade TEVA now
Teva Pharma Industries  primary media

About Teva Pharma Industries

Teva Pharma Industries (TLV:TEVA), (NYSE:TEVA) is a global pharmaceutical company with a focus on developing, producing, and marketing a wide range of generic and specialty medicines, as well as active pharmaceutical ingredients. Exclusively listed on the New York Stock Exchange under the ticker symbol NYSE:TEVA, the company operates in many countries worldwide. Teva is committed to increasing access to high-quality healthcare by developing, producing, and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active ingredients. The company’s projects span across various therapeutic areas including neurology, oncology, pain management, and respiratory diseases, aligning with its objectives to address unmet medical needs and to be a provider of choice for patients and healthcare professionals around the globe.

What is TEVA known for?

Snapshot

Public US
Ownership
1944
Year founded
27819
Employees
Tel Aviv, Israel
Head office
1 of 1
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
State of Israel

Produtos e/ou serviços de Teva Pharma Industries

  • Copaxone for multiple sclerosis, significantly impacting neurological treatment.
  • Austedo for Huntington's disease and tardive dyskinesia, offering neurodegenerative relief.
  • ProAir for asthma and COPD, indispensable in respiratory care.
  • Teva's generic drug portfolio, ensuring broad access to essential medicines.
  • Fremanezumab for migraine prevention, enhancing quality of life for sufferers.
  • Biosimilars in development, promising affordable alternatives in biologic therapy.

equipe executiva do Teva Pharma Industries

  • Mr. Richard D. FrancisPresident, CEO & Director
  • Mr. Eliyahu Sharon KalifExecutive VP & CFO
  • Mr. Richard Gordon DaniellExecutive Vice President of European Commercial
  • Dr. Eric A. Hughes M.D., Ph.D.Executive VP of Global R&D and Chief Medical Officer
  • Ms. Christine FoxExecutive VP of U.S. Commercial Business
  • Mr. Matthew ShieldsExecutive Vice President of Global Operations
  • Mr. Amir WeissSenior VP & Chief Accounting Officer
  • Mr. Christopher J. Stevo CFASenior Vice President of Investor Relations & Competitive Intelligence
  • Kathleen VeitSenior Vice President, Global Compliance & Ethics Officer
  • Mr. David R. Mcavoy J.D.Executive VP & Chief Legal Officer

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.